Search research articles
Contact Us
Filters
Showing results (561-570 of 1,025) with videos related to
Page
of 103
Sort By:
The American Journal of Cardiology
|
December 7, 2010
Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials)
Paul Frey, David D Waters, David A DeMicco, et al.
Current Medical Research and Opinion
|
October 1, 2010
Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2
J Wouter Jukema, Cheng-Wen Chiang, Jean Ferrières, et al.
Cardiovascular Drugs and Therapy
|
April 1, 1995
Antianginal efficacy and safety of controlled-delivery diltiazem QD versus an equivalent dose of immediate-release diltiazem TID
W P Klinke, M Baird, M Juneau, et al.
American Heart Journal
|
October 27, 2009
Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2
Raul D Santos, David D Waters, Lisa Tarasenko, et al.
The American Journal of Cardiology
|
November 11, 2008
Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study)
Colleen Johnson, David D Waters, David A DeMicco, et al.
Controlled Clinical Trials
|
September 1, 1987
Design features of a controlled clinical trial to assess the effect of a calcium entry blocker upon the progression of coronary artery disease
D Waters, D Freedman, J Lesperance, et al.
Medical and Pediatric Oncology
|
September 5, 2002
Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children
Stewart J Kellie, Christopher K F Wong, Luciano Dalla Pozza, et al.
Annals of Surgery
|
August 1, 1992
Preoperative and long-term cardiac risk assessment. Predictive value of 23 clinical descriptors, 7 multivariate scoring systems, and quantitative dipyridamole imaging in 360 patients
J Lette, D Waters, H Bernier, et al.
Mutation Research
|
March 1, 1992
International Commission for Protection Against Environmental Mutagens and Carcinogens. A method for comparing and combining short-term genotoxicity test data: the basic system
P H Lohman, M L Mendelsohn, D H Moore, et al.
Mutation Research
|
June 1, 1984
Evaluation of diallate and triallate herbicides for genotoxic effects in a battery of in vitro and short-term in vivo tests
S S Sandhu, M D Waters, K E Mortelmans, et al.
Page
of 103
Search research articles
Search
Showing results (561-570 of 1,025) with videos related to
Sort By:
Page
of 103
The American Journal of Cardiology
|
December 7, 2010
Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials)
Paul Frey, David D Waters, David A DeMicco, et al.
Current Medical Research and Opinion
|
October 1, 2010
Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2
J Wouter Jukema, Cheng-Wen Chiang, Jean Ferrières, et al.
Cardiovascular Drugs and Therapy
|
April 1, 1995
Antianginal efficacy and safety of controlled-delivery diltiazem QD versus an equivalent dose of immediate-release diltiazem TID
W P Klinke, M Baird, M Juneau, et al.
American Heart Journal
|
October 27, 2009
Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2
Raul D Santos, David D Waters, Lisa Tarasenko, et al.
The American Journal of Cardiology
|
November 11, 2008
Comparison of effectiveness of atorvastatin 10 mg versus 80 mg in reducing major cardiovascular events and repeat revascularization in patients with previous percutaneous coronary intervention (post hoc analysis of the Treating to New Targets [TNT] Study)
Colleen Johnson, David D Waters, David A DeMicco, et al.
Controlled Clinical Trials
|
September 1, 1987
Design features of a controlled clinical trial to assess the effect of a calcium entry blocker upon the progression of coronary artery disease
D Waters, D Freedman, J Lesperance, et al.
Medical and Pediatric Oncology
|
September 5, 2002
Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children
Stewart J Kellie, Christopher K F Wong, Luciano Dalla Pozza, et al.
Annals of Surgery
|
August 1, 1992
Preoperative and long-term cardiac risk assessment. Predictive value of 23 clinical descriptors, 7 multivariate scoring systems, and quantitative dipyridamole imaging in 360 patients
J Lette, D Waters, H Bernier, et al.
Mutation Research
|
March 1, 1992
International Commission for Protection Against Environmental Mutagens and Carcinogens. A method for comparing and combining short-term genotoxicity test data: the basic system
P H Lohman, M L Mendelsohn, D H Moore, et al.
Mutation Research
|
June 1, 1984
Evaluation of diallate and triallate herbicides for genotoxic effects in a battery of in vitro and short-term in vivo tests
S S Sandhu, M D Waters, K E Mortelmans, et al.
Page
of 103